US20020165355A1 - Methylated, SmD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus - Google Patents

Methylated, SmD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus Download PDF

Info

Publication number
US20020165355A1
US20020165355A1 US10/056,407 US5640702A US2002165355A1 US 20020165355 A1 US20020165355 A1 US 20020165355A1 US 5640702 A US5640702 A US 5640702A US 2002165355 A1 US2002165355 A1 US 2002165355A1
Authority
US
United States
Prior art keywords
peptide
peptides
antibodies
gly
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/056,407
Inventor
Lydie Meheus
Reinhard Luhrmann
Ann Union
Joseph Raymackers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Fujirebio Europe NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP97870127 priority Critical
Priority to EP97870127.4 priority
Priority to US09/297,981 priority patent/US6362007B1/en
Application filed by Fujirebio Europe NV SA filed Critical Fujirebio Europe NV SA
Priority to US10/056,407 priority patent/US20020165355A1/en
Publication of US20020165355A1 publication Critical patent/US20020165355A1/en
Abandoned legal-status Critical Current

Links